Correction: The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study (PLoS ONE (2017) 12:4 (e0175207) DOI: 10.1371/journal.pone.0175207)

10Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

Abstract

The images for Figs 4, 5, and 6 are incorrectly switched. The image that appears as Fig 4 should be Fig 5, the image that appears as Fig 5 should be Fig 6, and the image that appears as Fig 6 should be Fig 4. The figure captions appear in the correct order.

Cite

CITATION STYLE

APA

Correction: The impact of anti-drug antibodies on drug concentrations and clinical outcomes in rheumatoid arthritis patients treated with adalimumab, etanercept, or infliximab: Results from a multinational, real-world clinical practice, non-interventional study (PLoS ONE (2017) 12:4 (e0175207) DOI: 10.1371/journal.pone.0175207). (2017, June 1). PLoS ONE. Public Library of Science. https://doi.org/10.1371/journal.pone.0179308

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free